Cargando…

SORBS2 as a molecular target for atherosclerosis in patients with familial hypercholesterolemia

BACKGROUND: Familial hypercholesterolemia (FH) is a metabolic disease in which patients are prone to develop premature atherosclerosis (AS). Sorbin and SH3 Domain Containing 2 (SORBS2) is known to play a role in coronary heart disease (CHD). However, the mechanism underlying SORBS2 involvement in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ming-Ming, Peng, Jia, Guo, Yuan-Lin, Zhu, Cheng-Gang, Wu, Na-Qiong, Xu, Rui-Xia, Dong, Qian, Cui, Chuan-Jue, Li, Jian-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118763/ https://www.ncbi.nlm.nih.gov/pubmed/35590369 http://dx.doi.org/10.1186/s12967-022-03381-z

Ejemplares similares

Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia
por: Liu, Ming-Ming, et al.
Publicado: (2021)

Familial hypercholesterolemia in very young myocardial infarction
por: Li, Sha, et al.
Publicado: (2018)

Correlating corneal arcus with atherosclerosis in familial hypercholesterolemia
por: Zech, Loren A, et al.
Publicado: (2008)

Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia
por: Sharifi, Mahtab, et al.
Publicado: (2017)

Genetic basis of index patients with familial hypercholesterolemia in Chinese population: mutation spectrum and genotype-phenotype correlation
por: Sun, Di, et al.
Publicado: (2018)

Familial hypercholesterolemia supravalvular aortic stenosis and extensive atherosclerosis
por: Prajapati, Rajpal, et al.
Publicado: (2018)

Atherosclerosis severity in patients with familial hypercholesterolemia: The role of T and B lymphocytes
por: Fonzar, Waleria T., et al.
Publicado: (2022)

Idol Depletion Protects against Spontaneous Atherosclerosis in a Hamster Model of Familial Hypercholesterolemia
por: Liang, Chenxi, et al.
Publicado: (2022)

Improvement of Definite Diagnosis of Familial Hypercholesterolemia Using an Expanding Genetic Analysis
por: Cao, Ye-Xuan, et al.
Publicado: (2021)

A modified algorithm with lipoprotein(a) added for diagnosis of familial hypercholesterolemia
por: Sun, Di, et al.
Publicado: (2019)

The History of the WHHL Rabbit, an Animal Model of Familial Hypercholesterolemia (II): - Contribution to the Development and Validation of the Therapeutics for Hypercholesterolemia and Atherosclerosis -
por: Shiomi, Masashi
Publicado: (2020)

Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study
por: Pérez de Isla, Leopoldo, et al.
Publicado: (2023)

Cardiovascular Disease, Atherosclerosis and Familial Hypercholesterolemia: From Molecular Mechanisms Causing Pathogenicity to New Therapeutic Approaches
por: Jebari-Benslaiman, Shifa, et al.
Publicado: (2023)

Molecular diagnosis methods in familial hypercholesterolemia
por: Moldovan, Valeriu, et al.
Publicado: (2020)

Genetic and molecular architecture of familial hypercholesterolemia
por: Abifadel, Marianne, et al.
Publicado: (2022)

Biodegradation of sorbed chemicals in soil.
por: Scow, K M, et al.
Publicado: (1995)

CytoSorb-friend or foe!!
por: Pattnaik, Saroj Kumar, et al.
Publicado: (2015)

Transformation of non-water sorbing fly ash to a water sorbing material for drought management
por: Saha, Abhisekh, et al.
Publicado: (2020)

Vinexin family (SORBS) proteins regulate mechanotransduction in mesenchymal stem cells
por: Kuroda, Mito, et al.
Publicado: (2018)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

Analysis of Differentially Expressed Genes and Molecular Pathways in Familial Hypercholesterolemia Involved in Atherosclerosis: A Systematic and Bioinformatics Approach
por: Udhaya Kumar, S., et al.
Publicado: (2020)

Factors Associated with Carotid Atherosclerosis and Achilles Tendon Thickness in Japanese Patients with Familial Hypercholesterolemia: A Subanalysis of the Familial Hypercholesterolemia Expert Forum (FAME) Study
por: Ogura, Masatsune, et al.
Publicado: (2022)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

Characterization of Atherosclerosis Formation in a Murine Model of Type IIa Human Familial Hypercholesterolemia
por: Miyajima, Chiharu, et al.
Publicado: (2018)

“Apple does not fall far from the tree” – subclinical atherosclerosis in children with familial hypercholesterolemia
por: Podgórski, Michał, et al.
Publicado: (2020)

Subclinical atherosclerosis determined by coronary artery calcium deposition in patients with clinical familial hypercholesterolemia
por: Borg, Sanna á, et al.
Publicado: (2022)

Insulin-like growth factor 1 reduces coronary atherosclerosis in pigs with familial hypercholesterolemia
por: Sukhanov, Sergiy, et al.
Publicado: (2023)

Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease
por: Cao, Ye-Xuan, et al.
Publicado: (2018)

SORBS2 upregulation may contribute to dysfunction in LVNC via the Notch pathway: SORBS2 upregulation contributes to dysfunction
por: Li, Chunyan, et al.
Publicado: (2022)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Gene Therapy in a Humanized Mouse Model of Familial Hypercholesterolemia Leads to Marked Regression of Atherosclerosis
por: Kassim, Sadik H., et al.
Publicado: (2010)

Episomal Nonviral Gene Therapy Vectors Slow Progression of Atherosclerosis in a Model of Familial Hypercholesterolemia
por: Kerr, Alastair G, et al.
Publicado: (2016)

Mitochondrial Genetic Background May Impact Statins Side Effects and Atherosclerosis Development in Familial Hypercholesterolemia
por: Ruiz-Pesini, Eduardo, et al.
Publicado: (2022)

Substantially Elevated Atherosclerotic Risks in Japanese Severe Familial Hypercholesterolemia Defined by the International Atherosclerosis Society
por: Funabashi, Sayaka, et al.
Publicado: (2021)

Targeted Disruption of LDLR Causes Hypercholesterolemia and Atherosclerosis in Yucatan Miniature Pigs
por: Davis, Bryan T., et al.
Publicado: (2014)

Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis
por: Di Taranto, Maria Donata, et al.
Publicado: (2023)

Effects of castration on atherosclerosis in Yucatan minipigs with genetic hypercholesterolemia
por: Shim, Jeong T., et al.
Publicado: (2020)

Homozygous familial hypercholesterolemia
por: Parihar, Ravi Kumar, et al.
Publicado: (2012)

Homozygous Familial Hypercholesterolemia
por: Nohara, Atsushi, et al.
Publicado: (2021)

Cholesterol Metabolic Markers for Differential Evaluation of Patients with Hyperlipidemia and Familial Hypercholesterolemia
por: Li, Zhi-Zhao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g597db0143htliedong84jl3p6